Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome.
This study supports the importance of regulatory role of the E(2) in growth hormone secretion in women with polycystic ovary syndrome, showing for the first time a different weight-related sensitivity of the growth-hormone axis to hypoestrogenism induced by gonadotropin-releasing hormone agonist.
Villa
Paola
P
De Marinis
Laura
L
Mancini
Antonio
A
Guido
Maurizio
M
Selvaggi
Luigi
L
Lanzone
Antonio
A
D000328:Adult; D016022:Case-Control Studies; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000378:metabolism*; D017329:Triptorelin Pamoate / Q000494:pharmacology*
D017329:Triptorelin Pamoate; D019382:Human Growth Hormone; D007987:Gonadotropin-Releasing Hormone; D013007:Growth Hormone-Releasing Hormone